Luxturna success in Ireland
A 31-year-old Irishman can read again after becoming the country’s first patient to receive Luxturna to treat RPE65-inherited retinal dystrophy.
Staff reporters2 min read
Advertisement
A 31-year-old Irishman can read again after becoming the country’s first patient to receive Luxturna to treat RPE65-inherited retinal dystrophy.
A recent study of more than 280,000 people in Wales found the live-attenuated varicella zoster virus vaccine (Zostavax) reduced their risk of a new dementia diagnosis by 20% over a seven-year period.
A team of New Zealand researchers has shown that age appears to be a key factor influencing the underlying aetiology and clinical course of uveitis. Published in the American Journal of Ophthalmolog
Sandwiched between the brutalist concrete blocks of the Western Australia Commonwealth Court and the Perth Concert Hall, the Duxton Hotel was the setting for the 2025 Australian and New Zealand Glauco
A literature review comparing repeated low-level red light (RLRL) therapy with single vision spectacles (SVS) found RLRL treatment led to “considerable reductions” in both axial length (AL) and spheri
Alcon is cutting back on packaging material manufacturing and reducing waste going to NZ landfills.
The Therapeutics Products Act (TPA) 2023 has been repealed, despite being hailed by now-former health minister Dr Ayesha Verrall as the most significant change to the regulation of medicines, medical devices and natural health products in New Zealand in nearly 40 years.
BLVNZ is pulling the plug on its joint venture with Rotary to fund and operate a Southern Vision Bus.
CDR-Life is recruiting for phase 2 clinical trials of its novel antibody fragment-based therapy for geographic atrophy (GA), following favourable phase 1 safety results.
A groundbreaking, experimental stem cell treatment for blinding cornea injuries resulted in a 92% success rate at 18 months.
An Australian research team has developed a large language model (LLM) designed to speed up scientific discovery in molecular property prediction. Lead co-author, PhD candidate Yizhen Zheng, from Mo
An international team including New Zealand researchers found measures of retinal health captured the risk of Alzheimer's disease and related dementias (ADRD) across several domains of known risk fact